Skip to main content
  1. BAUS Home
  2. Professionals
  3. BAUS Business
  4. News

News

NICE approves use of new treatment for advanced metastatic bladder cancer

NICE approves use of new treatment for advanced metastatic bladder cancer

Enfortumab Vedotin combined with Pembrolizumab will now be available for eligible patients in the UK

The British Association of Urological Surgeons (BAUS) welcomes the decision by the National Institute for Health and Care Excellence (NICE) to approve the use of combination therapy enfortumab vedotin (Padcev) with pembrolizumab as a first-line... Read more

BAUS Launches "Check In, Don't Check Out" Awareness Campaign

BAUS Launches "Check In, Don't Check Out" Awareness Campaign

Surgeons urge men to prioritise their health during Men’s Health Awareness Week (10 – 16 June)

The majority of UK men would rather chat about things like the British weather or politics than have a potential life-saving conversation with a GP around their urological health. Data released today (Monday 9 June) indicates that nearly a... Read more

Rectal Exam a “Poor Test for Prostate Cancer” — Surgeons and Charity Agree

Rectal Exam a “Poor Test for Prostate Cancer” — Surgeons and Charity Agree

  The British Association of Urological Surgeons aligns with Prostate Cancer UK in declaring that men do not need a 'finger up the bum’ to test for prostate cancer.   Despite this, new data shows a third of men surveyed were still being... Read more

More Articles

Voting Results - Deputy Vice Presidents...

Response statement in relation to prostate...

Appointment of New Audit Steering Group...

Working Party on Sexual Misconduct in...

President's Aug 2023 Newsletter

Joint Statement on Outcome of BMA Ballot for...

BAUS: Our Urological Community

Hawassa Receives COSECSA Accreditation

Looking for other articles? Check the archive →